Kwality Pharmaceuticals Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 688.04 million compared to INR 640.47 million a year ago. Revenue was INR 702.64 million compared to INR 656.49 million a year ago. Net loss was INR 73.79 million compared to net income of INR 104.98 million a year ago. Basic loss per share from continuing operations was INR 7.23 compared to basic earnings per share from continuing operations of INR 9.97 a year ago. Diluted loss per share from continuing operations was INR 7.23 compared to diluted earnings per share from continuing operations of INR 9.97 a year ago.
For the full year, sales was INR 2,510.3 million compared to INR 4,561.85 million a year ago. Revenue was INR 2,539.71 million compared to INR 4,596.97 million a year ago. Net income was INR 193.72 million compared to INR 1,199.92 million a year ago. Basic earnings per share from continuing operations was INR 18.16 compared to INR 115.12 a year ago. Diluted earnings per share from continuing operations was INR 18.16 compared to INR 115.12 a year ago.